CD8A and myeloid sarcoma: MS patients demonstrated elevated expression of granzyme B, and reduced expression of PD-1, on MOG-specific CD8+ TEM, compared to HC (Figures 3A, D), as well as increased expression of granzyme B on MOG-specific CD8+ TCM, when compared with HC (Figure 3F).